January 30, 2018 / 12:06 PM / 10 months ago

BRIEF-Dova Pharmaceuticals Announces Appointment Of Mark W. Hahn As Chief Financial Officer

Jan 30 (Reuters) - Dova Pharmaceuticals Inc:

* DOVA PHARMACEUTICALS ANNOUNCES THE APPOINTMENT OF MARK W. HAHN AS CHIEF FINANCIAL OFFICER

* DOVA PHARMACEUTICALS INC - ‍DOUG BLANKENSHIP, DOVA’S PREVIOUS CHIEF FINANCIAL OFFICER, HAS AGREED TO STEP DOWN​

* DOVA PHARMACEUTICALS INC - MARK WILL OFFICIALLY COMMENCE IN HIS ROLE AS CHIEF FINANCIAL OFFICER OF DOVA ON JANUARY 31, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below